



PSSI, SI, CDI, RNWK, REGN, SYNA Expected To Be Down After Next Earnings Releases
Published in Stocks and Investing on Wednesday, July 27th 2011 at 7:02 GMT by WOPRAI

July 27, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, July 28th 2011 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and June earnings reports. PSS WORLD MEDICAL INCORPORATED (NASDAQ:PSSI), SIEMENS AG-SPONS ADR (NYSE:SI), CDI CORP (NYSE:CDI), REALNETWORKS INC (NASDAQ:RNWK), REGENERON PHARMACEUTICALS (NASDAQ:REGN), SYNAPTICS INC (NASDAQ:SYNA) are all expected to be Down After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down After earnings are released Thursday:
Symbol Company # of Reports Quarter Release Time PSSI PSS WORLD MEDICAL INCORPORATED 6 Quarter Q1 Before SI SIEMENS AG-SPONS ADR 12 Quarter Q3 Before CDI CDI CORP 6 Quarter Q2 Before RNWK REALNETWORKS INC July Earnings Q2 After REGN REGENERON PHARMACEUTICALS 12 Quarter Q2 Before SYNA SYNAPTICS INC 6 Quarter Q4 AfterThis technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.
PSS WORLD MEDICAL INCORPORATED (NASDAQ:PSSI) - PSS World Medical, Inc., together with its subsidiaries, distributes medical products and equipment, pharmaceutical products, healthcare information technology, and billing services to alternate-site healthcare providers in the United States. It operates in two segments, Physician Business and Elder Care Business. The Physician Business segment distributes approximately 158,600 various products consisting of medical-surgical disposable supplies, pharmaceuticals, diagnostic equipment, non-diagnostic equipment, and healthcare information technology solutions. As of April 2, 2010, it operated a distribution network consisting of 27 full-service distribution centers, 34 break-freight locations, and 2 redistribution facilities. The Elder Care Business segment distributes approximately 47,100 medical and related products consisting of medical supplies, incontinent supplies and personal care items, enteral feeding supplies, point of care testing devices, advanced wound care, home medical equipment, and other supplies required by the long-term care patient. It also provides Medicare Part B and Medicaid billing services to the assisted living market. This segment serves independent, regional, and national nursing home facilities, home health agencies, assisted living centers, hospices, and home medical equipment dealers. As of the above date, it operated a distribution network consisting of 13 full-service distribution centers, 7 break-freight locations, 6 ancillary service centers, and 2 redistribution centers. The company was founded in 1983 and is based in Jacksonville, Florida.
SIEMENS AG-SPONS ADR (NYSE:SI) - Siemens Aktiengesellschaft, an electronics and electrical engineering company, operates in the industry, energy, and healthcare sectors worldwide. In the industry sector, the companys portfolio ranges from industry automation and drives products and services to building, lighting, and mobility solutions and services, as well as includes system integration and solutions for plant business. It offers automation and drives, industrial solutions and services, transportation systems, Siemens building technologies, and OSRAM lighting solutions. In the energy sector, Siemens provides solutions for the generation, transmission, and distribution of power; and extraction, conversion, and transport of oil and gas in the oil and gas industry. In the healthcare sector, it develops, manufactures, and markets diagnostic and therapeutic systems, devices, and consumables; and offers IT systems for clinical and administrative purposes. The company also provides technical maintenance, professional, consulting, and financing services. In addition, Siemens offers IT solutions and services comprising consulting, design, and implementation services; outsourcing services; and software development, as well as information and communications systems. Further, it provides financial products and services, such as commercial finance, equity and project finance, treasury and investment management, and project and export finance. Additionally, the company offers insurance solutions, such as claims management; and acts as a broker of company-financed insurances, as well as engages in real estate business. It also has equity investments in a telecommunications infrastructure supplier, household appliance, defense technology, and communication and entertainment device companies, as well as in companies that provide technical building equipment and installation services; and open communications, network, and security solutions. The company was founded in 1847 and is headquartered in Munich, Germany.
CDI CORP (NYSE:CDI) - CDI Corp. provides engineering and information technology outsourcing solutions and professional staffing services primarily in the United States, the United Kingdom, and Canada. It operates in four segments: ES, MRI, Anders, and ITS. The ES segment provides engineering, design, project management, professional staffing, and outsourcing solutions to oil, gas, refining, alternative energy, power generation and energy transmission, nuclear, chemicals, and heavy manufacturing industries; engineering, design, and logistics services to the defense industry, primarily in marine design, systems development, and military aviation support; and a range of engineering, design, project management, professional staffing, and outsourcing solutions to the commercial and military aerospace markets. This segment also offers facility design, project management, engineering, professional staffing, and facility start-up services to customers in the pharmaceutical, bio-pharmaceutical, and regulated medical services industries. The MRI segment operates as a global franchisor that does business as MRINetwork and provides the use of its trademarks, business systems, and training and support services to its franchisees who engage in the search and recruitment of executive, technical, professional, and managerial personnel for employment by their customers. It also provides training, implementation services, and back-office services to enable franchisees to pursue staffing opportunities. The Anders segment provides contract and permanent placement candidates to customers in the infrastructure environment seeking staff in building, construction, and related professional services. The ITS segment offers various information technology related services, which include staffing augmentation, permanent placement, outsourcing, and consulting. The company was founded in 1950 and is based in Philadelphia, Pennsylvania.
REALNETWORKS INC (NASDAQ:RNWK) - RealNetworks, Inc. provides network-delivered digital media products and services worldwide. It develops and markets software products and services that enable the creation, distribution, and consumption of digital media, including audio and video. The company operates in four segments: Technology Products and Solutions (TPS), Media Software and Services (MSS), Games, and Music. The TPS segment primarily offers software-as-a-service offerings, which include ringback tones, music-on-demand, video-on-demand, and messaging services, as well as system software license sales and intellectual property licensing. This segment also licenses Helix server software that allows companies to broadcast live and on-demand audio, video, and other multimedia programming to users over the Internet. The MSS segment offers RealPlayer, a media player software, which includes features and services that enable consumers to discover, play, download, manage, and edit digital video. The Games segment offers various casual games available through digital downloads or online portals, social networks, and mobile devices. This segment also involves in game development, publishing, licensing, and distribution. It distributes games principally in North America, Europe, and Latin America through the companys own Web sites, which are operated under the GameHouse, RealArcade, Zylom, and Atrativa brands, and through Web sites owned or managed by third parties. In addition, this segment develops and distributes games for other platforms, including mobile phones, other handheld devices, and videogame consoles. The Music segment offers Rhapsody, a subscription and advertising-supported music service; Rhapsody.com, a free Web-based limited version digital music service; and Rhapsody MP3 music store, where consumers purchase and download individual digital music tracks. The company was founded in 1994 and is headquartered in Seattle, Washington.
REGENERON PHARMACEUTICALS (NASDAQ:REGN) - Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions in the United States. The companys commercial product includes ARCALYST (rilonacept) injection for subcutaneous use for the treatment of cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome in adults and children. Its products under Phase III clinical trials include Rilonacept for the prevention and treatment of gout-related flares; VEGF Trap-Eye for eye diseases using intraocular delivery; and Aflibercept for the treatment of oncology. The companys earlier stage clinical programs REGN475, an antibody to nerve growth factor, which is being developed for the treatment of pain; REGN88, an antibody to the interleukin-6 receptor, which is developed in rheumatoid arthritis; REGN421, an antibody to delta-like ligand-4, for the treatment of oncology; REGN727, an antibody to proprotein convertase substilisin/kexin type 9, which is developed for low density lipoprotein cholesterol reduction; and REGN668, an antibody to the interleukin-4 receptor for certain allergic and immune conditions. Regeneron Pharmaceuticals also conducts other preclinical research programs in the areas of oncology and angiogenesis, ophthalmology, metabolic and related diseases, muscle diseases and disorders, inflammation and immune diseases, bone and cartilage, pain, cardiovascular diseases, and infectious diseases. The company has strategic collaboration with sanofi-aventis Group to discover, develop, and commercialize fully human monoclonal antibodies; and Bayer HealthCare LLC for the development of the VEGF-Trap-Eye. Regeneron Pharmaceuticals was founded in 1988 and is based in Tarrytown, New York.
SYNAPTICS INC (NASDAQ:SYNA) - Synaptics Incorporated develops and supplies custom-designed human interface solutions that enable people to interact with various mobile computing, communications, entertainment, and other electronic devices. The company provides custom interface solutions for navigation, cursor control, and multimedia controls for PC original equipment manufacturers (OEMs). It primarily targets the personal computer (PC) market and the market for digital lifestyle products, including mobile smartphones and feature phones, portable digital music and video players, and other select electronic device markets with its customized interface solutions. In addition to notebooks, other PC applications for the companys technology include peripherals, such as keyboards, mice, and monitors, as well as desktop and PC remote control applications. Its solutions for the PC market primarily include the TouchPad, a touch-sensitive pad that senses the position of a persons finger on its surface; the TouchStyk, an integrated pointing stick module; and dual pointing solutions, which combine both a TouchPad and a pointing stick into a single notebook computer enabling the users to use the interface of their choice. The companys user interface solutions for digital lifestyle products comprise the ScrollStrip and TouchRing, which are scrolling solutions that enable users to navigate through menus and content; LightTouch capacitive buttons, which provide illuminated button functionality; and MobileTouch, NavPoint, and ClearTouch solutions. Synaptics sells its products to PC OEMs, as well as to various consumer electronics manufacturers primarily in the United States, Taiwan, China, Korea, Japan, Hong Kong, Switzerland, Singapore, and Malaysia. The company was founded in 1986 and is based in Santa Clara, California.
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641